A new strategy for pharmacodynamic substance screening and research on gut microbiota pathway mechanisms based on UPLC-Q-orbitrap-MS and 16S rRNA

MLA

Yu, Zhiying, et al. “A New Strategy for Pharmacodynamic Substance Screening and Research on Gut Microbiota Pathway Mechanisms Based on UPLC-Q-Orbitrap-MS and 16S RRNA.” Journal of Traditional Chinese Medical Sciences, no. Preprints, Jan. 2024. EBSCOhost, https://doi.org/10.1016/j.jtcms.2024.11.008.

APA

Yu, Z., Li, T., Yang, J., He, J., Zhang, W., Li, S., Qi, Y., Yin, Y., Dong, L., & Xu, W. (2024). A new strategy for pharmacodynamic substance screening and research on gut microbiota pathway mechanisms based on UPLC-Q-orbitrap-MS and 16S rRNA. Journal of Traditional Chinese Medical Sciences, Preprints. https://doi.org/10.1016/j.jtcms.2024.11.008

Chicago

Yu, Zhiying, Tong Li, Jie Yang, Jianghua He, Weijiang Zhang, Siyuan Li, Yunpeng Qi, Yihui Yin, Ling Dong, and Wenjuan Xu. 2024. “A New Strategy for Pharmacodynamic Substance Screening and Research on Gut Microbiota Pathway Mechanisms Based on UPLC-Q-Orbitrap-MS and 16S RRNA.” Journal of Traditional Chinese Medical Sciences, no. Preprints (January). doi:10.1016/j.jtcms.2024.11.008.